10034
phase combinatorial synthesis of biologically active compounds containing the histidine and
histamine cores and the result will be reported in due course.
Acknowledgements
This work was supported by grants from the Korea Science and Engineering Foundation
through Center for Molecular Catalysis. J.S.P. and J.H.C. thank the Brain Korea 21 Program
of the Ministry of Education, Korea for their BK21 fellowships.
References
1. Zydowsky, T. M.; Dellaria Jr., J. F.; Nellans, H. N. J. Org. Chem. 1988, 53, 5607.
2. Hagelu¨ken, A.; Grunbau¨m, L.; Klinker, J. F.; Nu¨rnberg, B.; Harhammer, R.; Schultz, G.; Leschke, C.; Schunack,
W.; Seifert, R. Biochem. Pharmacol. 1995, 49, 901.
3. Blankley, C. J.; Hodges, J. C.; Klutchko, S. R.; Himmelsbach, R. J.; Chucholowski, A.; Connolly, C. J.;
Neergaard, S. J.; Van Nieuwenhze, M. S.; Sebastian, A.; Quin III, J.; Essenburg, A. D.; Cohen, D. M. J. Med.
Chem. 1991, 34, 3248.
4. Sieber, P.; Riniker, B. Tetrahedron Lett. 1987, 28, 6031.
5. (a) Jones, J. H.; Ramage, W. I. J. Chem. Soc., Chem. Commun. 1978, 472; (b) Fletcher, A. R.; Jones, J. H.;
Ramage, W. I.; Stachulski, A. V. J. Chem. Soc., Perkin Trans. 1 1979, 2261.
6. (a) Colombo, R.; Colombo, F.; Jones, J. H. J. Chem. Soc., Chem. Commun. 1984, 292; (b) Brown, T.; Jones, J.
H.; Richards, J. D. J. Chem. Soc., Perkin Trans. 1 1982, 1553.
7. Brown, T.; Jones, J. H. J. Chem. Soc., Chem. Commun. 1981, 648.
8. Hodges, J. C. Synthesis 1987, 20.
9. Chivikas, C. J.; Hodges, J. C. J. Org. Chem. 1987, 52, 3591.
10. Eleftheriou, S.; Gatos, D.; Panagopoulos, A.; Stathopoulos, S.; Barlos, K. Tetrahedron Lett. 1999, 40, 2825.
11. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis; Wiley: New York, 1991; p. 387.
12. Apelqvist, T.; Wensbo, D. Tetrahedron Lett. 1996, 37, 1471.
13. General procedure: To a stirred solution of N(a)-Trt-N(t)-Trt-L-histidine methyl ester (0.10 g, 0.15 mmol) in 0.50
mL of DMF was added benzyl bromide (0.13 g, 0.77 mmol). The reaction mixture was allowed to stir for 48 h
at 50°C. When the reaction was complete (monitored by HPLC), the solvent was removed under reduced
pressure. Excess benzyl bromide was removed by filtering through a pad of silica gel (5% methanol in CH2Cl2).
The crude product was dissolved in 5% methanol in CH2Cl2 (6.0 mL). To the solution was added a 0.01 M TFA
solution in CH2Cl2 (0.02 mL, 0.15 mol%) and activated silica gel (2.0 g, preactivated under 0.1 mPa at 50°C for
12 h). The slurry was allowed to stir for 24 h at room temperature. The reaction mixture was filtered and washed
with 5% methanolic methylene chloride solution (15 mL×5). The combined filtrate was concentrated and purified
on silica gel chromatography (from CH2Cl2 to CH2Cl2:MeOH=95:5) to give N(a)-Trt-N(p)-benzyl-L-histidine
1
methyl ester (0.060 g, 0.12 mmol, 80% yield). Rf=0.60 (CH2Cl2:MeOH=95:5); H NMR (500 MHz, CDCl3) l
7.33 (s, 1H), 7.22–7.02 (m, 20H), 6.76 (s, 1H), 4.92 (s, 2H), 3.20 (m, 1H), 2.88 (s, 3H), 2.72 (m, 2H), 1.47 (br, 1H);
13C NMR (75 MHz, CDCl3) l 174.51, 145.58, 138.11, 136.04, 128.98, 127.95, 127.86, 126.75, 126.54, 126.48,
77.21, 71.03, 56.81, 51.49, 48.49, 30.31; IR (KBr, neat) 3358, 3057, 2927, 1731, 1684, 1599, 1486, 1448, 1373,
1250, 1207, 1169, 1113, 1033, 706 cm−1; LCMS (m/z) 502.7 (M+H)+ for C33H31N3O; HRFABMS (M+1)+ calcd
for C33H31N3O2 502.2416, found 502.2478.
.
.